These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

676 related items for PubMed ID: 16761228

  • 21. A dose-ranging study of indacaterol in obstructive airways disease, with a tiotropium comparison.
    Rennard S, Bantje T, Centanni S, Chanez P, Chuchalin A, D'Urzo A, Kornmann O, Perry S, Jack D, Owen R, Higgins M.
    Respir Med; 2008 Jul; 102(7):1033-44. PubMed ID: 18479895
    [Abstract] [Full Text] [Related]

  • 22. [Tiotropium (Spiriva) - a long-acting inhaled anticholinergic for the treatment of chronic obstructive pulmonary disease (COPD)].
    Beeh KM, Welte T, Buhl R.
    Pneumologie; 2003 Sep; 57(9):519-25. PubMed ID: 13680472
    [Abstract] [Full Text] [Related]

  • 23. Impact of tiotropium on the course of moderate-to-very severe chronic obstructive pulmonary disease: the UPLIFT trial.
    Tashkin DP.
    Expert Rev Respir Med; 2010 Jun; 4(3):279-89. PubMed ID: 20524910
    [Abstract] [Full Text] [Related]

  • 24. Efficacy of tiotropium in COPD patients from Asia: a subgroup analysis from the UPLIFT trial.
    Fukuchi Y, Fernandez L, Kuo HP, Mahayiddin A, Celli B, Decramer M, Kesten S, Liu D, Tashkin D.
    Respirology; 2011 Jul; 16(5):825-35. PubMed ID: 21539680
    [Abstract] [Full Text] [Related]

  • 25. Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: a placebo-controlled trial.
    Tashkin DP, Littner M, Andrews CP, Tomlinson L, Rinehart M, Denis-Mize K.
    Respir Med; 2008 Apr; 102(4):479-87. PubMed ID: 18258423
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effects of tiotropium or combined therapy with salmeterol on hyperinflation in COPD.
    Eguchi Y, Tateishi Y, Umeda N, Yoshikawa T, Kamoi H, Kanazawa H, Kudoh S, Hirata K, Fujimoto S.
    Osaka City Med J; 2007 Jun; 53(1):25-34. PubMed ID: 17867631
    [Abstract] [Full Text] [Related]

  • 30. Effect of tiotropium bromide on the cardiovascular response to exercise in COPD.
    Travers J, Laveneziana P, Webb KA, Kesten S, O'Donnell DE.
    Respir Med; 2007 Sep; 101(9):2017-24. PubMed ID: 17475459
    [Abstract] [Full Text] [Related]

  • 31. Changes in lung function and health status in patients with COPD treated with tiotropium or salmeterol plus fluticasone.
    Kurashima K, Hara K, Yoneda K, Kanauchi T, Kagiyama N, Tokunaga D, Takayanagi N, Ubukata M, Sugita Y.
    Respirology; 2009 Mar; 14(2):239-44. PubMed ID: 19210650
    [Abstract] [Full Text] [Related]

  • 32. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
    O'Donnell DE, Laveneziana P, Ora J, Webb KA, Lam YM, Ofir D.
    Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
    [Abstract] [Full Text] [Related]

  • 33. Efficacy of tiotropium in COPD patients with FEV1 ≥ 60% participating in the UPLIFT® trial.
    Tashkin DP, Celli BR, Decramer M, Lystig T, Liu D, Kesten S.
    COPD; 2012 Jun; 9(3):289-96. PubMed ID: 22432932
    [Abstract] [Full Text] [Related]

  • 34. [Early treatment of COPD with tiotropium].
    Buhl R, Welte T, Vogelmeier C, Gillissen A, Voshaar T, Kögler H, Liu D, Glaab T.
    Pneumologie; 2012 Oct; 66(10):589-95. PubMed ID: 23011771
    [Abstract] [Full Text] [Related]

  • 35. [The efficacy of tiotropium bromide (spiriva) in the treatment of patients with chronic obstructive pulmonary disease of varying severity: results of the Russian trial].
    Stepanian IE, Khmel'kova NG, Belin-Atarac B.
    Ter Arkh; 2010 Oct; 82(10):46-51. PubMed ID: 21341464
    [Abstract] [Full Text] [Related]

  • 36. Double-blind randomized parallel group study comparing the efficacy and safety of tiotropium and ipratropium in the treatment of COPD patients in Taiwan.
    Hsu JY, Perng RP, Lu JY, Wu CP, Huang MS, Luh KT, Yang PC.
    J Formos Med Assoc; 2006 Sep; 105(9):708-14. PubMed ID: 16959618
    [Abstract] [Full Text] [Related]

  • 37. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
    Tashkin DP.
    Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901
    [Abstract] [Full Text] [Related]

  • 38. A pilot study to assess the effects of combining fluticasone propionate/salmeterol and tiotropium on the airflow obstruction of patients with severe-to-very severe COPD.
    Cazzola M, Andò F, Santus P, Ruggeri P, Di Marco F, Sanduzzi A, D'Amato M.
    Pulm Pharmacol Ther; 2007 Oct; 20(5):556-61. PubMed ID: 16914336
    [Abstract] [Full Text] [Related]

  • 39. The effect of tiotropium on exacerbations and airflow in patients with COPD.
    Dusser D, Bravo ML, Iacono P.
    Eur Respir J; 2006 Mar; 27(3):547-55. PubMed ID: 16507855
    [Abstract] [Full Text] [Related]

  • 40. Tiotropium 5microg via Respimat and 18microg via HandiHaler; efficacy and safety in Japanese COPD patients.
    Ichinose M, Fujimoto T, Fukuchi Y.
    Respir Med; 2010 Feb; 104(2):228-36. PubMed ID: 19969446
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.